Wall Street Journal Eli Lilly Reports Dramatic Weight Loss in Next-Gen Obesity-Drug Trial This post was originally published on this site. Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a late-stage trial. By Peter Loftus and Nicholas G. MillerDecember 11, 2025No comment